I agree that this site is using cookies. You can find further informations
here
.
X
Login
Merkliste (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
zur Desktop-Version
Toggle navigation
Merkliste
1 Ergebnisse
1
The DANTE trial protocol: a randomised phase III trial to e..:
Oliver Coen
;
Pippa Corrie
;
Helen Marshall
...
https://doi.org/10.1186/s12885-021-08509-w. , 2021
Link:
https://doi.org/10.1186/s12885-021-08509-w
RT Journal T1
The DANTE trial protocol: a randomised phase III trial to evaluate the Duration of ANti-PD-1 monoclonal antibody Treatment in patients with metastatic mElanoma
UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:94e82f3219214bb495cb4463d0ad4aed&Exemplar=1&LAN=DE A1 Oliver Coen A1 Pippa Corrie A1 Helen Marshall A1 Ruth Plummer A1 Christian Ottensmeier A1 Jane Hook A1 Sue Bell A1 Gurdeep S. Sagoo A1 David Meads A1 Janine Bestall A1 Galina Velikova A1 Ferdia A. Gallagher A1 Alexandra Smith A1 Helen Howard A1 Ellen Mason A1 Eszter Katona A1 Shobha Silva A1 Michelle Collinson A1 Simon Rodwell A1 Sarah Danson PB BMC YR 2021 K1 Immunotherapy K1 Checkpoint inhibitor K1 Anti-PD-1 K1 Metastatic melanoma K1 Schedule K1 Efficacy K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens K1 RC254-282 JF https://doi.org/10.1186/s12885-021-08509-w LK http://dx.doi.org/https://doi.org/10.1186/s12885-021-08509-w DO https://doi.org/10.1186/s12885-021-08509-w SF ELIB - SuUB Bremen
Export
RefWorks (nur Desktop-Version!)
Flow
(Zuerst in
Flow
einloggen, dann importieren)